Cancer Letters
Volume 226, Issue 1 , Pages 49-54 , 8 August 2005

A genetic polymorphism in prostaglandin synthase 2 (8473, T→C) and the risk of lung cancer

  • Mette Sørensen

      Affiliations

    • Institute of Cancer Epidemiology, The Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen O, Denmark
    • Corresponding Author InformationCorresponding author. Tel.: +45 35257626; fax: +45 35257731.
    • ,
  • Herman Autrup

      Affiliations

    • Department of Environmental and Occupational Medicine, University of Aarhus, DK-8000 Aarhus, Denmark
    • ,
  • Anne Tjønneland

      Affiliations

    • Institute of Cancer Epidemiology, The Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen O, Denmark
    • ,
  • Kim Overvad

      Affiliations

    • Department of Clinical Epidemiology, Aalborg Hospital, Aarhus University Hospital, DK-9000 Aalborg, Denmark
    • ,
  • Ole Raaschou-Nielsen

      Affiliations

    • Institute of Cancer Epidemiology, The Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen O, Denmark

Received 31 January 2005 ,Revised 26 March 2005 ,Accepted 28 March 2005.

References 

  1. Koki A, Khan NK, Woerner BM, Dannenberg AJ, Olson L, Seibert K, et al. Cyclooxygenase-2 in human pathological disease. Adv. Exp. Med. Biol. 2002;507:177–184
  2. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998;93:705–716
  3. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl Acad. Sci. USA. 1997;94:3336–3340
  4. Hsu AL, Ching TT, Wang DS, Song X, Rangnekar VM, Chen CS. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J. Biol. Chem. 2000;275:11397–11403
  5. Khuri FR, Wu H, Lee JJ, Kemp BL, Lotan R, Lippman SM, et al. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin. Cancer Res. 2001;7:861–867
  6. Shishodia S, Potdar P, Gairola CG, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis. 2003;24:1269–1279
  7. Martey CA, Pollock SJ, Turner CK, O'Reilly KM, Baglole CJ, Phipps RP, et al. Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004;287:L981–L991
  8. Campa D, Zienolddiny S, Maggini V, Skaug V, Haugen A, Canzian F. Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis. 2004;25:229–235
  9. Tjonneland AM, Overvad OK. Diet, cancer and health—a population study and establishment of a biological bank in Denmark. Ugeskr Laeger. 2000;162:350–354
  10. Sorensen M, Autrup H, Tjonneland A, Overvad K, Raaschou-Nielsen O. Glutathione S-transferase T1 null-genotype is associated with an increased risk of lung cancer. Int. J. Cancer. 2004;110:219–224
  11. Storm HH. The Danish cancer registry: a self-reporting national cancer registration system with elements of active data collection. IARC Sci. Publ. 1991;220–236
  12. Barlow WE, Ichikawa L, Rosner D, Izumi S. Analysis of case-cohort designs. J. Clin. Epidemiol. 1999;52:1165–1172
  13. Barlow WE. Robust variance estimation for the case-cohort design. Biometrics. 1994;50:1064–1072
  14. Vogel U, Laros I, Jacobsen NR, Thomsen B, Bak H, Olsen A, et al. Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. Mutat. Res. 2004;546:65–74
  15. Cox DG, Pontes C, Guino E, Navarro M, Osorio A, Canzian F, et al. Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer. Br. J. Cancer. 2004;91:339–343
  16. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 2001;10:1239–1248

PII: S0304-3835(05)00289-2

doi: 10.1016/j.canlet.2005.03.037

Cancer Letters
Volume 226, Issue 1 , Pages 49-54 , 8 August 2005

Article Tools